GLP-1 Medications: What Weight-Loss Drugs Mean for the Future of Orthopedics Theyve taken over the headlines and social media feedsOzempic, Wegovy, Mounjaro, Zepboundnames youve seen on TV or even discussed at the dinner table
Some are approved for obesity treatment in certain settings
Sermorelin doesnt create muscle mass through pharmacological anabolism the way exogenous testosterone does
233 Sodium-glucose cotransporter-2 (SGLT2) inhibitors are commonly used for type 2 diabetes treatment, and in recent years, SGLT2 inhibitors canagliflozin has been shown to suppress IL-6 and IL-1 levels and MPO enzyme activity in the colon of UC rats by downregulating the expression of NF-B p65, thereby reducing colonic inflammatory cell infiltration and oxidative stress
We conducted a retrospective analysis of the FDA Adverse Event Reporting System (FAERS) database from 2018 through 2024
Researchers investigate how simultaneous receptor stimulation influences pulsatile hormone communication, anabolic signaling frameworks, and endocrine feedback regulation models
